Skip to main content

Advertisement

Log in

WHO guidelines for treatment of tuberculosis: the missing links

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Treatment of Tuberculosis Guidelines; 2009. Report No.: WHO/HTM/TB/2009/420. ISBN: 9789241547833.

  2. World Health Organization. Preamble to the constitution of the World Health Organization as adopted by the International Health Conference. International Health Conference; New York. 1946 [cited 1 May 2012]; Available from: http://whqlibdoc.who.int/hist/official_records/constitution.pdf.

  3. Spilker B. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Philadelphia; 1996. ISBN: 0781703328.

  4. Rajeswari R, Muniyandi M, Balasubramanian R, Narayanan PR. Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med. 2005;60(8):1845–53.

    Article  PubMed  CAS  Google Scholar 

  5. Sherbourne CD, Sturm R, Wells KB. What outcomes matter to patients? J Gen Intern Med. 1999;14(6):357–63.

    Article  PubMed  CAS  Google Scholar 

  6. Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes. 2004;2(1):58.

    Article  PubMed  Google Scholar 

  7. Hansel NN, Wu AW, Chang B, Diette GB. Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res. 2004;13(3):639–52.

    Article  PubMed  Google Scholar 

  8. Macq J, Solis A, Martinez G, Martiny P, Dujardin B. An exploration of the social stigma of tuberculosis in five. Health Policy. 2005;74(2):205–17.

    Article  PubMed  Google Scholar 

  9. Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic. Health Qual Life Outcomes. 2009;7:14.

    Article  PubMed  Google Scholar 

  10. Dhuria M, Sharma N, Ingle GK. Impact of tuberculosis on the quality of life. Indian J Commun Med. 2008;33(1):58–9.

    Article  Google Scholar 

  11. Dhingra VK, Rajpal S. Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis–additional evaluative tool under DOTS. J Commun Dis. 2005;37(4):261–8.

    PubMed  CAS  Google Scholar 

  12. Li LM, Bai LQ, Yang HL, Xiao CF, Tang RY, Chen YF, et al. Sputum induction to improve the diagnostic yield in patients with suspected pulmonary tuberculosis notes from the field. Int J Tuberc Lung Dis. 1999;3(12):1137–9.

    PubMed  CAS  Google Scholar 

  13. Parry CM, Kamoto O, Harries AD, Wirima JJ, Nyirenda CM, Nyangulu DS, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis. 1995;6(1):72–6.

    Article  Google Scholar 

  14. Leigh TR, Hume C, Gazzard B, Parsons P, Husain OAN, Collins JV. Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1989;334(8656):205–6.

    Article  Google Scholar 

  15. Shata AM, Coulter JB, Parry CM, Ching’ani G, Broadhead RL, Hart CA. Sputum induction for the diagnosis of tuberculosis. Arch Dis Child. 1996;74(6):535–7.

    Article  PubMed  CAS  Google Scholar 

  16. Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99(1):9–13.

    Article  PubMed  CAS  Google Scholar 

  17. Schoeffel RE, Anderson SD, Altounyan RE. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed). 1981;283(6302):1285–7.

    Article  CAS  Google Scholar 

  18. Gonzalez-Angulo Y, Wiysonge CS, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, Hatherill M. Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2011 [Epub ahead of print]. Available from: http://www.springerlink.com/content/er6674p5785711rg/.

  19. Crofton J, Horne NW, Miller F. Clinical tuberculosis. London: The Macmillan Education Limited; 2008. ISBN: 140509737X.

  20. Atif M, Sulaiman SAS, Shafie AA, Muttalif AR, Ali I, Saleem F. Applying patient centered approach in management of pulmonary tuberculosis: a case report from Malaysia. J Basic Clin Pharm. 2011;2(3):129–31.

    Google Scholar 

  21. Mason J, Reynolds R, Rao N. The systemic safety of fexofenadine HCl. Clin Exp Allergy. 1999;29(S3):163–70.

    Google Scholar 

  22. Mattila MJ, Paakkari I. Variations among non-sedating antihistamines: are there real differences? Eur J Clinical Pharmacol. 1999;55(2):85–93.

    Article  CAS  Google Scholar 

  23. Woodward JK. Pharmacology of antihistamines. J Allergy Clin Immunol. 1990;86(4):606–12.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

Authors would like to thank Institute of Postgraduate Studies (IPS) at University Sains Malaysia for their financial support in carrying out this work through USM-RU-PRGS (1001/PFARMASI/844011).

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad Atif.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atif, M., Sulaiman, S.A.S., Shafie, A.A. et al. WHO guidelines for treatment of tuberculosis: the missing links. Int J Clin Pharm 34, 506–509 (2012). https://doi.org/10.1007/s11096-012-9657-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-012-9657-8

Keywords

Navigation